Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 15, 2021
Date of Patent
October 31, 2023
Patent Applicant
Enanta Pharmaceuticals
Enanta Pharmaceuticals
Patent Application Number
17201308
Patent Citations
‌
US Patent 7741494 Histone deacetylase inhibitors
‌
US Patent 7232825 Phenylaminopyrimidine derivatives and methods of use
‌
US Patent 7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors
‌
US Patent 7411003 Inhibition of Hepatitis B virus by cyclohexenone compounds from
‌
US Patent 7615569 Inhibitors of ion channels
‌
US Patent 10189846 Hepatitis B antiviral agents
‌
US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound
‌
US Patent 10428070 Hepatitis B antiviral agents
‌
US Patent 10538532 Hepatitis B antiviral agents
‌
US Patent 10640511 Hepatitis B antiviral agents
•••
Patent Inventor Names
Samuel Bartlett
Dexter Davis
Joseph D. Panarese
Yat Sun Or
Nathaniel Thomas Kenton
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11802125
Patent Primary Examiner
‌
Niloofar Rahmani
CPC Code
‌
A61K 45/06
‌
C07D 471/04

Find more entities like US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.